1,846
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Antimicrobial and anti-inflammatory properties of Funtumia elastica

, , &
Pages 418-425 | Received 04 May 2012, Accepted 05 Oct 2012, Published online: 22 Jan 2013

Figures & data

Table 1.  Preliminary phytochemical screening of ethanol leaf (FLE) and stem bark (FBE) extracts of F. elastica.

Table 2.  Antimicrobial activity of ethanol leaf extract (FLE) and ethanol stem bark extract (FBE) of F. elastica by agar diffusion method.

Table 3.  Minimum inhibitory concentration (MIC) (mg/mL) of ethanol leaf extract (FLE) and ethanol stem bark extract (FBE) of F. elastica determined by microdilution method.

Figure 1.  The effects of 30, 100, and 300 mg/kg of ethanolic stem bark extract (FBE) on carrageenan-induced inflammation in chicks. ***implies p < 0.001 which signifies a significant reduction in foot volume at all dose levels. Data are presented as mean ± SEM (n = 5), analyzed by one-way ANOVA followed by Newman-Keuls test for column graphs. Control is the untreated group.

Figure 1.  The effects of 30, 100, and 300 mg/kg of ethanolic stem bark extract (FBE) on carrageenan-induced inflammation in chicks. ***implies p < 0.001 which signifies a significant reduction in foot volume at all dose levels. Data are presented as mean ± SEM (n = 5), analyzed by one-way ANOVA followed by Newman-Keuls test for column graphs. Control is the untreated group.

Figure 2.  The effects of 30, 100, and 300 mg/kg of ethanolic leaf extract (FLE) on carrageenan-induced inflammation in chicks. ***implies p < 0.001 which signifies a significant reduction in foot volume at all dose levels. Data are presented as mean ± SEM (n = 5), analyzed by one-way ANOVA followed by Newman-Keuls test for column graphs. Control is the untreated group.

Figure 2.  The effects of 30, 100, and 300 mg/kg of ethanolic leaf extract (FLE) on carrageenan-induced inflammation in chicks. ***implies p < 0.001 which signifies a significant reduction in foot volume at all dose levels. Data are presented as mean ± SEM (n = 5), analyzed by one-way ANOVA followed by Newman-Keuls test for column graphs. Control is the untreated group.

Figure 3.  The effects of 0.25, 0.5, and 1.0 mg/kg of dexamethasone on carrageenan-induced inflammation in chicks. ***implies p < 0.001, which signifies a significant reduction in foot volume at all dose levels. Data are presented as mean ± SEM (n = 5), analyzed by one-way ANOVA followed by Newman-Keuls test for column graphs. Control is the untreated group.

Figure 3.  The effects of 0.25, 0.5, and 1.0 mg/kg of dexamethasone on carrageenan-induced inflammation in chicks. ***implies p < 0.001, which signifies a significant reduction in foot volume at all dose levels. Data are presented as mean ± SEM (n = 5), analyzed by one-way ANOVA followed by Newman-Keuls test for column graphs. Control is the untreated group.

Figure 4.  The effects of 10, 30, and 100 mg/kg of diclofenac on carrageenan-induced inflammation in chicks. ***implies p < 0.001, which signifies a significant reduction in foot volume at all dose levels. Data are presented as mean ± SEM (n = 5), analyzed by one-way ANOVA followed by Newman-Keuls test for column graphs.Control is the untreated group.

Figure 4.  The effects of 10, 30, and 100 mg/kg of diclofenac on carrageenan-induced inflammation in chicks. ***implies p < 0.001, which signifies a significant reduction in foot volume at all dose levels. Data are presented as mean ± SEM (n = 5), analyzed by one-way ANOVA followed by Newman-Keuls test for column graphs.Control is the untreated group.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.